We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 11-20 of 335

Motion to Strike Pleadings Relating to Additional Acts of Infringement within the Defendant's Knowledge Dismissed
  • Borden Ladner Gervais LLP
  • Canada
  • April 6 2016

Canadian Tire brought a motion to strike two sentences from each of five paragraphs in the Statement of Claim. In the alternative, particulars were


Improper priority claim is not a material allegation which renders patent void under s.53
  • Borden Ladner Gervais LLP
  • Canada
  • April 6 2016

This was a patent infringement action, relating to an invention that pertains to a fast, uniform and contactless method of crosslinking polymers


Appeal of a decision to not strike out Statement of Claim in its entirety dismissed
  • Borden Ladner Gervais LLP
  • Canada
  • April 6 2016

The Court dismissed Teva Canada Limited's appeal from the Prothonotary's Order declining to strike out Gilead's Statement of Claim in its entirety


Appeal of a decision to not bifurcate a s.8 action and infringement counterclaim dismissed
  • Borden Ladner Gervais LLP
  • Canada
  • March 23 2016

The appeal of a Prothonotary's decision to refuse to bifurcate liability and quantification of an action comprising a claim pursuant to section 8 of


Pleading amended to refer to prior art that may not be proven to be prior art
  • Borden Ladner Gervais LLP
  • Canada
  • March 16 2016

The Defendants sought to amend their Statement of Defence to include reference to a product referred to as prior art in support of their allegation


Motion challenging the listing of a patent on the patent register filed before the 2015 amendments to the PM(NOC) Regulations is decided on the basis of the old regulations
  • Borden Ladner Gervais LLP
  • Canada
  • March 16 2016

Apotex has successfully challenged the listing of a patent on the Patent Register pursuant to Paragraph 4(2)(a) of the PM(NOC) Regulations. The


Supreme Court Leave to Appeal Granted
  • Borden Ladner Gervais LLP
  • Canada
  • March 16 2016

The Supreme Court has granted AstraZeneca leave to appeal in its application which asks the correct applicable standard for patent utility in Canada


Supreme Court Upcoming Leave to Appeal Decisions
  • Borden Ladner Gervais LLP
  • Canada
  • March 9 2016

The Supreme Court will announce the result of a leave application which asks the correct applicable standard for patent utility in Canada and whether


Compound patent held to be not soundly predicted for the level of promised utility found by the Court
  • Borden Ladner Gervais LLP
  • Canada
  • February 24 2016

The Federal Court has dismissed an application for prohibition concerning the drug ALIMTA. Although the parties joined issue on a significant number


S.53 of the Patent Act held Not to Apply when Public Servant Fails to Declare Status
  • Borden Ladner Gervais LLP
  • Canada
  • February 18 2016

In this case, Brown appealed a decision of the Federal Court, partially granting summary judgment in an invalidity claim, pursuant to s. 53 of the